Fig. 1From: Challenges and opportunities for improving the landscape for Lewy body dementia clinical trialsConsiderations and an example for optimizing LBD clinical trial design. CSF, cerebrospinal fluid; DLB, dementia with Lewy bodies; LBD, Lewy body dementia; MCI, mild cognitive impairment; PDD, Parkinson’s disease dementiaBack to article page